Role of p38 mitogen-activated protein kinase in cardiac myocyte secretion of the inflammatory cytokine TNF-α

被引:65
作者
Ballard-Croft, C [1 ]
White, DJ [1 ]
Maass, DL [1 ]
Hybki, DP [1 ]
Horton, JW [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Surg, Dallas, TX 75390 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2001年 / 280卷 / 05期
关键词
rat model of burn trauma; Langendorff perfusion; cardiac contraction-relaxation; tumor necrosis factor-alpha;
D O I
10.1152/ajpheart.2001.280.5.H1970
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study examined the hypothesis that burn trauma promotes cardiac myocyte secretion of inflammatory cytokines such as tumor necrosis factor (TNF)-alpha and produces cardiac contractile dysfunction via the p38 mitogen-activated protein kinase (MAPK) pathway. Sprague-Dawley rats were divided into four groups: 1) sham burn rats given anesthesia alone, 2) sham burn rats given the p38 MAPK inhibitor SB203580 (6 mg/kg po, 15 min; 6- and 22-h postburn), 3) rats given third-degree burns over 40% total body surface area and treated with vehicle (1 ml of saline) plus lactated Ringer solution for resuscitation (4 ml.kg(-1).percent burn(-1)), and 4) burn rats given injury and fluid resuscitation plus SB203580. Rats from each group were killed at several times postburn to examine p38 MAPK activity (by Western blot analysis or in vitro kinase assay); myocardial function and myocyte secretion of TNF-alpha were examined at 24-h postburn. These studies showed significant activation of p38 MAPK at 1-, 2-, and 4-h postburn compared with time-matched shams. Burn trauma impaired cardiac mechanical performance and promoted myocyte secretion of TNF-alpha. SB203580 inhibited p38 MAPK activity, reduced myocyte secretion of TNF-alpha, and prevented burn-mediated cardiac deficits. These data suggest p38 MAPK activation is one aspect of the signaling cascade that culminates in postburn secretion of TNF-alpha and contributes to postburn cardiac dysfunction.
引用
收藏
页码:H1970 / H1981
页数:12
相关论文
共 58 条
[1]   EFFICACY AND SAFETY OF MONOCLONAL-ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH SEPSIS SYNDROME - A RANDOMIZED, CONTROLLED, DOUBLE-BLIND, MULTICENTER CLINICAL-TRIAL [J].
ABRAHAM, E ;
WUNDERINK, R ;
SILVERMAN, H ;
PERL, TM ;
NASRAWAY, S ;
LEVY, H ;
BONE, R ;
WENZEL, RP ;
BALK, R ;
ALLRED, R ;
PENNINGTON, JE ;
WHERRY, JC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (12) :934-941
[2]   p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock - A randomized controlled multicenter trial [J].
Abraham, E ;
Glauser, MP ;
Butler, T ;
Garbino, J ;
Gelmont, D ;
Laterre, PF ;
Kudsk, K ;
Bruining, HA ;
Otto, C ;
Tobin, E ;
Zwingelstein, C ;
Lesslauer, W ;
Leighton, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (19) :1531-1538
[3]   DECREASED CONTRACTILITY AND COMPLIANCE OF THE LEFT-VENTRICLE AS COMPLICATIONS OF THERMAL TRAUMA [J].
ADAMS, HR ;
BAXTER, CR ;
IZENBERG, SD .
AMERICAN HEART JOURNAL, 1984, 108 (06) :1477-1487
[4]  
Badger AM, 1996, J PHARMACOL EXP THER, V279, P1453
[5]  
Badger AM, 1998, J IMMUNOL, V161, P467
[6]  
BADGER AM, 1989, CIRC SHOCK, V27, P51
[7]   Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-α [J].
Bryant, D ;
Becker, L ;
Richardson, J ;
Shelton, J ;
Franco, F ;
Peshock, R ;
Thompson, M ;
Giroir, B .
CIRCULATION, 1998, 97 (14) :1375-1381
[8]   Tumor necrosis factor-α and interleukin-1β synergistically depress human myocardial function [J].
Cain, BS ;
Meldrum, DR ;
Dinarello, CA ;
Meng, XZ ;
Joo, KS ;
Banerjee, A ;
Harken, AH .
CRITICAL CARE MEDICINE, 1999, 27 (07) :1309-1318
[9]   p38 MAPK inhibition decreases TNF-α production and enhances postischemic human myocardial function [J].
Cain, BS ;
Meldrum, DR ;
Meng, XZ ;
Dinarello, CA ;
Shames, BD ;
Banerjee, A ;
Harken, AH .
JOURNAL OF SURGICAL RESEARCH, 1999, 83 (01) :7-12
[10]   Therapeutic strategies to reduce TNF-α mediated cardiac contractile depression following ischemia and reperfusion [J].
Cain, BS ;
Harken, AH ;
Meldrum, DR .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1999, 31 (05) :931-947